Abstract
Summary
The global Calprotectin IVD Test market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Calprotectin IVD Test players cover CerTest Biotec, Lomina, Svar Life Science, Alpha Laboratories, Actim, Eagle Bioscience, Inc, Abbexa Ltd, BÜHLMANN Laboratories and Boditech Med, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Calprotectin IVD Test Industry Forecast” looks at past sales and reviews total world Calprotectin IVD Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Calprotectin IVD Test sales for 2023 through 2029. With Calprotectin IVD Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calprotectin IVD Test industry.
This Insight Report provides a comprehensive analysis of the global Calprotectin IVD Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Calprotectin IVD Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Calprotectin IVD Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calprotectin IVD Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calprotectin IVD Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Calprotectin IVD Test market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Lateral Flow Immunoassay (LFIA) Test
ELISA Test
Segmentation by application
Hospitals
Diagnostic Laboratories
Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CerTest Biotec
Lomina
Svar Life Science
Alpha Laboratories
Actim
Eagle Bioscience, Inc
Abbexa Ltd
BÜHLMANN Laboratories
Boditech Med
DIAsource ImmunoAssays
R-Biopharm
AccuBio Tech
Screen Italia
Hangzhou Biotest Biotech
Fujian Proglead
BaSO
Key Questions Addressed in this Report
What is the 10-year outlook for the global Calprotectin IVD Test market?
What factors are driving Calprotectin IVD Test market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Calprotectin IVD Test market opportunities vary by end market size?
How does Calprotectin IVD Test break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Calprotectin IVD Test is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Calprotectin IVD Test players cover CerTest Biotec, Lomina, Svar Life Science, Alpha Laboratories, Actim, Eagle Bioscience, Inc, Abbexa Ltd, BÜHLMANN Laboratories and Boditech Med, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Calprotectin IVD Test Industry Forecast” looks at past sales and reviews total world Calprotectin IVD Test sales in 2022, providing a comprehensive analysis by region and market sector of projected Calprotectin IVD Test sales for 2023 through 2029. With Calprotectin IVD Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calprotectin IVD Test industry.
This Insight Report provides a comprehensive analysis of the global Calprotectin IVD Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Calprotectin IVD Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Calprotectin IVD Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calprotectin IVD Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calprotectin IVD Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Calprotectin IVD Test market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Lateral Flow Immunoassay (LFIA) Test
ELISA Test
Segmentation by application
Hospitals
Diagnostic Laboratories
Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CerTest Biotec
Lomina
Svar Life Science
Alpha Laboratories
Actim
Eagle Bioscience, Inc
Abbexa Ltd
BÜHLMANN Laboratories
Boditech Med
DIAsource ImmunoAssays
R-Biopharm
AccuBio Tech
Screen Italia
Hangzhou Biotest Biotech
Fujian Proglead
BaSO
Key Questions Addressed in this Report
What is the 10-year outlook for the global Calprotectin IVD Test market?
What factors are driving Calprotectin IVD Test market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Calprotectin IVD Test market opportunities vary by end market size?
How does Calprotectin IVD Test break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Calprotectin IVD Test Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Calprotectin IVD Test by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Calprotectin IVD Test by Country/Region, 2018, 2022 & 2029
2.2 Calprotectin IVD Test Segment by Type
2.2.1 Lateral Flow Immunoassay (LFIA) Test
2.2.2 ELISA Test
2.3 Calprotectin IVD Test Sales by Type
2.3.1 Global Calprotectin IVD Test Sales Market Share by Type (2018-2023)
2.3.2 Global Calprotectin IVD Test Revenue and Market Share by Type (2018-2023)
2.3.3 Global Calprotectin IVD Test Sale Price by Type (2018-2023)
2.4 Calprotectin IVD Test Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Specialty Clinics
2.5 Calprotectin IVD Test Sales by Application
2.5.1 Global Calprotectin IVD Test Sale Market Share by Application (2018-2023)
2.5.2 Global Calprotectin IVD Test Revenue and Market Share by Application (2018-2023)
2.5.3 Global Calprotectin IVD Test Sale Price by Application (2018-2023)
3 Global Calprotectin IVD Test by Company
3.1 Global Calprotectin IVD Test Breakdown Data by Company
3.1.1 Global Calprotectin IVD Test Annual Sales by Company (2018-2023)
3.1.2 Global Calprotectin IVD Test Sales Market Share by Company (2018-2023)
3.2 Global Calprotectin IVD Test Annual Revenue by Company (2018-2023)
3.2.1 Global Calprotectin IVD Test Revenue by Company (2018-2023)
3.2.2 Global Calprotectin IVD Test Revenue Market Share by Company (2018-2023)
3.3 Global Calprotectin IVD Test Sale Price by Company
3.4 Key Manufacturers Calprotectin IVD Test Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Calprotectin IVD Test Product Location Distribution
3.4.2 Players Calprotectin IVD Test Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Calprotectin IVD Test by Geographic Region
4.1 World Historic Calprotectin IVD Test Market Size by Geographic Region (2018-2023)
4.1.1 Global Calprotectin IVD Test Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Calprotectin IVD Test Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Calprotectin IVD Test Market Size by Country/Region (2018-2023)
4.2.1 Global Calprotectin IVD Test Annual Sales by Country/Region (2018-2023)
4.2.2 Global Calprotectin IVD Test Annual Revenue by Country/Region (2018-2023)
4.3 Americas Calprotectin IVD Test Sales Growth
4.4 APAC Calprotectin IVD Test Sales Growth
4.5 Europe Calprotectin IVD Test Sales Growth
4.6 Middle East & Africa Calprotectin IVD Test Sales Growth
5 Americas
5.1 Americas Calprotectin IVD Test Sales by Country
5.1.1 Americas Calprotectin IVD Test Sales by Country (2018-2023)
5.1.2 Americas Calprotectin IVD Test Revenue by Country (2018-2023)
5.2 Americas Calprotectin IVD Test Sales by Type
5.3 Americas Calprotectin IVD Test Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Calprotectin IVD Test Sales by Region
6.1.1 APAC Calprotectin IVD Test Sales by Region (2018-2023)
6.1.2 APAC Calprotectin IVD Test Revenue by Region (2018-2023)
6.2 APAC Calprotectin IVD Test Sales by Type
6.3 APAC Calprotectin IVD Test Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Calprotectin IVD Test by Country
7.1.1 Europe Calprotectin IVD Test Sales by Country (2018-2023)
7.1.2 Europe Calprotectin IVD Test Revenue by Country (2018-2023)
7.2 Europe Calprotectin IVD Test Sales by Type
7.3 Europe Calprotectin IVD Test Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Calprotectin IVD Test by Country
8.1.1 Middle East & Africa Calprotectin IVD Test Sales by Country (2018-2023)
8.1.2 Middle East & Africa Calprotectin IVD Test Revenue by Country (2018-2023)
8.2 Middle East & Africa Calprotectin IVD Test Sales by Type
8.3 Middle East & Africa Calprotectin IVD Test Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Calprotectin IVD Test
10.3 Manufacturing Process Analysis of Calprotectin IVD Test
10.4 Industry Chain Structure of Calprotectin IVD Test
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Calprotectin IVD Test Distributors
11.3 Calprotectin IVD Test Customer
12 World Forecast Review for Calprotectin IVD Test by Geographic Region
12.1 Global Calprotectin IVD Test Market Size Forecast by Region
12.1.1 Global Calprotectin IVD Test Forecast by Region (2024-2029)
12.1.2 Global Calprotectin IVD Test Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Calprotectin IVD Test Forecast by Type
12.7 Global Calprotectin IVD Test Forecast by Application
13 Key Players Analysis
13.1 CerTest Biotec
13.1.1 CerTest Biotec Company Information
13.1.2 CerTest Biotec Calprotectin IVD Test Product Portfolios and Specifications
13.1.3 CerTest Biotec Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CerTest Biotec Main Business Overview
13.1.5 CerTest Biotec Latest Developments
13.2 Lomina
13.2.1 Lomina Company Information
13.2.2 Lomina Calprotectin IVD Test Product Portfolios and Specifications
13.2.3 Lomina Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lomina Main Business Overview
13.2.5 Lomina Latest Developments
13.3 Svar Life Science
13.3.1 Svar Life Science Company Information
13.3.2 Svar Life Science Calprotectin IVD Test Product Portfolios and Specifications
13.3.3 Svar Life Science Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Svar Life Science Main Business Overview
13.3.5 Svar Life Science Latest Developments
13.4 Alpha Laboratories
13.4.1 Alpha Laboratories Company Information
13.4.2 Alpha Laboratories Calprotectin IVD Test Product Portfolios and Specifications
13.4.3 Alpha Laboratories Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alpha Laboratories Main Business Overview
13.4.5 Alpha Laboratories Latest Developments
13.5 Actim
13.5.1 Actim Company Information
13.5.2 Actim Calprotectin IVD Test Product Portfolios and Specifications
13.5.3 Actim Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Actim Main Business Overview
13.5.5 Actim Latest Developments
13.6 Eagle Bioscience, Inc
13.6.1 Eagle Bioscience, Inc Company Information
13.6.2 Eagle Bioscience, Inc Calprotectin IVD Test Product Portfolios and Specifications
13.6.3 Eagle Bioscience, Inc Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eagle Bioscience, Inc Main Business Overview
13.6.5 Eagle Bioscience, Inc Latest Developments
13.7 Abbexa Ltd
13.7.1 Abbexa Ltd Company Information
13.7.2 Abbexa Ltd Calprotectin IVD Test Product Portfolios and Specifications
13.7.3 Abbexa Ltd Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbexa Ltd Main Business Overview
13.7.5 Abbexa Ltd Latest Developments
13.8 BÜHLMANN Laboratories
13.8.1 BÜHLMANN Laboratories Company Information
13.8.2 BÜHLMANN Laboratories Calprotectin IVD Test Product Portfolios and Specifications
13.8.3 BÜHLMANN Laboratories Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BÜHLMANN Laboratories Main Business Overview
13.8.5 BÜHLMANN Laboratories Latest Developments
13.9 Boditech Med
13.9.1 Boditech Med Company Information
13.9.2 Boditech Med Calprotectin IVD Test Product Portfolios and Specifications
13.9.3 Boditech Med Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Boditech Med Main Business Overview
13.9.5 Boditech Med Latest Developments
13.10 DIAsource ImmunoAssays
13.10.1 DIAsource ImmunoAssays Company Information
13.10.2 DIAsource ImmunoAssays Calprotectin IVD Test Product Portfolios and Specifications
13.10.3 DIAsource ImmunoAssays Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 DIAsource ImmunoAssays Main Business Overview
13.10.5 DIAsource ImmunoAssays Latest Developments
13.11 R-Biopharm
13.11.1 R-Biopharm Company Information
13.11.2 R-Biopharm Calprotectin IVD Test Product Portfolios and Specifications
13.11.3 R-Biopharm Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 R-Biopharm Main Business Overview
13.11.5 R-Biopharm Latest Developments
13.12 AccuBio Tech
13.12.1 AccuBio Tech Company Information
13.12.2 AccuBio Tech Calprotectin IVD Test Product Portfolios and Specifications
13.12.3 AccuBio Tech Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 AccuBio Tech Main Business Overview
13.12.5 AccuBio Tech Latest Developments
13.13 Screen Italia
13.13.1 Screen Italia Company Information
13.13.2 Screen Italia Calprotectin IVD Test Product Portfolios and Specifications
13.13.3 Screen Italia Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Screen Italia Main Business Overview
13.13.5 Screen Italia Latest Developments
13.14 Hangzhou Biotest Biotech
13.14.1 Hangzhou Biotest Biotech Company Information
13.14.2 Hangzhou Biotest Biotech Calprotectin IVD Test Product Portfolios and Specifications
13.14.3 Hangzhou Biotest Biotech Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hangzhou Biotest Biotech Main Business Overview
13.14.5 Hangzhou Biotest Biotech Latest Developments
13.15 Fujian Proglead
13.15.1 Fujian Proglead Company Information
13.15.2 Fujian Proglead Calprotectin IVD Test Product Portfolios and Specifications
13.15.3 Fujian Proglead Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Fujian Proglead Main Business Overview
13.15.5 Fujian Proglead Latest Developments
13.16 BaSO
13.16.1 BaSO Company Information
13.16.2 BaSO Calprotectin IVD Test Product Portfolios and Specifications
13.16.3 BaSO Calprotectin IVD Test Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 BaSO Main Business Overview
13.16.5 BaSO Latest Developments
14 Research Findings and Conclusion